Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats

Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 6, 2006, Pages 853-857

  Bao, Ande ^a   Phillips, William T ^a   Goins, Beth ^a   McGuff, Howard S ^b   Zheng, Xiangpeng ^b   Woolley, F Ross ^a   Natarajan, Mohan ^a   Santoyo, Cristina ^a   Miller, Frank R ^a   Otto, Randal A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER SIZE; CELL STRAIN; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INOCULATION; MALE; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; RAT; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION; TISSUE SECTION; TUMOR GROWTH; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 33751415721     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.06.1257     Document Type: Article

References (18)

1. Prasad M.L., and Huvos A.G. Pathology of head and neck tumorsIn. In: Shah J.P. (Ed). American Cancer Society atlas of clinical oncology: cancer of the head and neck (2001), BC Decker, London 19-55
2. Halfpenny W., Hain S.F., Biassoni L., et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 86 (2002) 512-516
3. Kostakoglu L., and Goldsmith S.J. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 45 (2004) 56-68
4. Nagatsuka H., Hibi K., Gunduz M., et al. Various immunostaining patterns of CD31, CD34 and endoglin and their relationship with lymph node metastasis in oral squamous cell carcinoma. J Oral Pathol 34 (2005) 70-76
5. Bao A., Phillips W.T., Goins B., et al. Potential use of drug-carried liposomes for cancer therapy via direct intratumoral injection. Intl J Pharm 316 (2006) 162-169
6. Tomayco M.M., and Reynolds C.P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24 (1989) 148-154
7. Sorensen G.A., Patel S., Harmath C., et al. Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19 (2001) 551-557
8. Modjtahedi H., Eccles S., Box G., et al. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction. Br J Cancer 67 (1993) 254-261
9. Mendelsohn J., and Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21 (2003) 2787-2799
10. Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
11. Guillermo P.J., Janne P.A., Lee J.C., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
12. Miller F.R., Hussey D., Beerman M., et al. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 131 (2005) 626-629
13. Dearling J.L.J., Flynn A.A., Sutcliffe-Goulden J., et al. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J Nucl Med 45 (2004) 101-107
14. 64Cu-ATSM: A comparison study with FDG. Nucl Med Biol 30 (2003) 529-534
15. Weber W.A. Brown adipose tissue and nuclear medicine imaging. J Nucl Med 45 (2004) 1101-1103
16. Jain R.K., and Baxter L.T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 48 (1988) 7022-7032
17. Heldin C.-H., Rubin K., Pietras K., et al. High interstitial fluid pressure-an obstacle in cancer therapy. Nature Rev Cancer 4 (2004) 806-813
18. Funk T., Sun M., and Hasegawa B.H. Radiation dose estimate in small animal SPECT and PET. Med Phys 31 (2004) 2680-2686